DETERMINAN KEJADIAN NEUROPATI PERIFER PADA PASIEN DIABETES MELITUS TIPE 2
DOI:
https://doi.org/10.33143/jhtm.v11i2.5328Kata Kunci:
Age, Comorbidities, Peripheral NeuropathyAbstrak
Diabetes Melitus (DM) menyebabkan gangguan sirkulasi yang dapat menyebabkan penderitanya mengalami komplikasi mikrovaskuler. Salah satu komplikasi mikrovaskuler adalah hilangnya sensasi pada daerah tungkai kaki (neuropati perifer) yang akan menimbulkan ulkus pada kaki dan risiko amputasi. Penelitian ini bertujuan untuk mengetahui hubungan lama diabetes melitus tipe-2 dengan Diabetic Peripheral Neurophaty (DPN) pada pasien diabetes melitus tipe 2 di rumah sakit umum milik pemerintah kota di sebuah provinsi Indonesia. Metode Penelitian kuantitatif dengan desain cross-sectional studi dilakukan pada 154 pasien diabetes melitus tipe 2 (DMT2) yang berkunjung ke poliklinik penyakit dalam di rumah sakit umum milik pemerintah kota di sebuah provinsi Indonesia dengan teknik proportionate stratifified random sampling. Data diperoleh dengan menggunakan kuesioner demografi dan Michigan Diabetic Neuropathy Score dan dianalisa menggunakan uji Chi-square dan Regresi Logistik. Hasil penelitian menunjukkan bahwa DPN berhubungan signifikan dengan sub-variabel Usia dengan Penyakit Penyerta pada pasien DMT2 (p<0,05). Kesimpulan ada hubungan yang signifikan antara usia, dan penyakit penyerta dengan kejadian DPN pada pasien DMT2 di rumah sakit umum milik pemerintah kota di sebuah provinsi Indonesia. Saran Kepada pasien diharapkan agar dapat melakukan managemen diabetes dengan baik sehingga tidak ada lagi pasien diabetes yang luka akibat komplikasi yang ditimbulkan dari neuropati. Direkomendasikan kepada rumah sakit agar rutin memberikan pendidikan kesehatan tentang risiko perkembangan neuropati dan pencegahan terjadinya komplikasi serius yang diakibatkan oleh neuropati perifer.
Keyword: Usia, Penyakit Penyerta, Neuropati Perifer
Referensi
American Diabetes Association. 2016. “Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers.” Clinical Diabeltels 34(1):3–21. doi: 10.2337/diaclin 34.1.3.
Amour, Ahlam A., Nyasatu Chamba, Johnstonel Kayandabila, Isaack A. Lyaruu, Delkkelr Marielkel, ELlichilia R. Shao, and William Howleltt. 2019. “Prevalence, Patterns, and Factors Associated with Peripheral Neuropathies among Diabetic Patients at Telrtiary Hospital in the Kilimanjaro Region: Descriptive Cross-Sectional Study from North-Eastern Tanzania.” International Journal of Endocrinology 2019. doi: 10.1155/2019/5404781.
Andi Baso Tombong. 2021. “*Corresponding Author: Long-Standing Type 2 Diabetes Mellitus Is Related to Neuropathy Incidence: A Cross-Sectional Study.” Confelrhelnsif Helalth Carel 5(1):32–43.
Hébelrt, Harry L., Abirami Velluchamy, Nicola Torrancel, and Blair H. Smith. 2017. “Risk Factors for Neuropathic Pain in Diabetic Mellitus.” Pain 158(4):560–68. doi: 10.1097/j.pain.0000000000000785.
IDF. 2017. Eighth Edition 2017.
Kementerian Kesehatan RI. 2020. “Infodatin Teltap Produktif, Celgah, Dan Atasi Diabeltels Mellitus 2020.” Pusat Data Dan Informasi Kelmelntelrian Kelselhatan RI 1–10.
Malik, Rayaz A., Aimelel Andag-Silva, Charungthai Deljthelvaporn, Manfaluthy Hakim, Jasminel S. Koh, Rizaldy Pinzon, Norlella Sukor, and Ka Sing Wong. 2020. “Diagnosing Peripheral Neuropathy in South-East Asia: A Focus on Diabetic Neuropathy.” Journal of Diabetes Investigation 11(5):1097–1103. doi: 10.1111/jdi.13269.
Nisansala, M. W. Nilushi, Savithri W. Wimalaselkelra, and Thamara D. Amaraselkara. 2022. “Peripheral Neuropathy Sensation of Patients with Type 2 Diabetes Mellitus Cross-Sectional Study.” International Journal of Community Medicine and Health:2749. doi: 10.18203/2394-6040.ijcmph20221734.
Tofurel, Ian Risaldy, Laura B. S. Huwael, and ELka Astuty. 2021. “KARAKTELRISTIK PASIELN PELNDELRITA NELUROPATI PELRIFELR DIABELTIK DI POLIKLINIK SARAF RSUD Dr. M. HAULUSSY AMBON TAHUN 2016-2019.” Molucca Meldica 14(Dm):97–108. doi: 10.30598/molmeld.2021.v14.i2.97.
Won, J. C., H. S. Kwon, C. H. Kim, J. H. Lelel, T. S. Park, K. S. Ko, and B. Y. Cha. 2012. “Prevalence Clinical Characteristics Diabetic Peripheral Neuropathy Hospital Patients Type 2 Diabetes Related.” Diabetic Medicinal 9:290 96. doi: 10.1111/j.1464-5491.2012.03697.x.
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
I. ORIGINALITY, AUTHORSHIP, AND COPYRIGHT
The manuscripts submitted for publication must be research works written in English that have not been previously published and  are not being considered for publication elsewhere. All the authors must have agreed to the submission and to the order of their names on the title page. They must also have agreed that the corresponding author may act on their behalf throughout the editorial review and publication process. The corresponding author is responsible for obtaining such agreement.
Requests for changes in authorship (order of listing or addition or deletion of names) after submission should be accompanied by signed statements of agreement from all the parties involved. To maintain and protect the publisher‘s ownership and rights and to protect the original authors from misappropriations of their published work, author(s) are required to sign a Journal Publishing Agreement and send it to the editorial office (jhtm@uui.ac.id).
II. PERMISSION
The author is responsible for acquiring the permission(s) to reproduce any copyrighted figures, tables, data, or text that are being used in the submitted paper. Authors should note that text quotations of more than 250 words from a published or copyrighted work will require grant of permission from the original publisher to reprint. The written permission letter(s) must be submitted together with the manuscript.
III. EDITORIAL REVIEW AND REVISION
All papers will be critically read by at least two anonymous reviewers, selected for their competence in the subject area of the paper. Acceptance of the paper will depend upon its scientific merit and suitability for the journal. A paper may be accepted in its original form or subject to revision.
The reviewers' (and editor's) suggestions will be conveyed to the author, who will then have an opportunity to revise the paper. A manuscript returned to an author for revision can be held for a maximum of eight weeks.
The accepted paper will be edited by native English speakers. The cost of language editing service is currently free.
IV. PROOFS
Galley proofs (PDF format) for an accepted article will be sent by e-mail to the corresponding author for copyediting corrections. The core content of an article cannot be changed at this time. It is the author's responsibility to check the entire manuscript, including tables, figure legends, and cited reference numbers, not just the items queried. The proofs should be corrected and mailed to the editorial office within 48 hours of receipt in order to expedite publication. Only one set of corrections will be accepted. In other words, it is important to ensure that all of your corrections are sent to us in one communication.
V. Â REPRINTS
Five free reprint copies of the published article will be shipped to the corresponding authors in Indonesia only, approximately two weeks after the issue is printed. Authors, including overseas authors, who wish to purchase reprints, are required to complete the Reprint Order Form, which will be sent with the galley proofs to corresponding authors. This form must be returned together with the corrected galley proofs.
